Opinion statement
Acquired and congenital nystagmus often causes decreased visual acuity as a direct result of the inability to maintain stable foveal vision. In addition, acquired nystagmus causes a disabling subjective sensation of movement of the visual world called oscillopsia. The eye movements themselves do not require treatment if the patient is asymptomatic. However, therapy is necessary if visual disability is present. Treatments based in pharmacologic mechanisms are preferred. There are few controlled treatment trials and therapeutic efficacy generally is sought in a trial and error approach, depending on the type of nystagmus present. Treatment with 3,4-diaminopyridine and 4-aminopyridine recently have been shown to be effective for downbeat nystagmus. Gabapentin, baclofen, and clonazepam also are useful in some patients with downbeat nystagmus. Baclofen is the therapy of choice for periodic alternating nystagmus. Gabapentin often is effective for acquired pendular nystagmus. Clonazepam and valproate also may be effective for acquired pendular nystagmus. Memantine now is available in the United States and is promising in the treatment of pendular nystagmus. Optical devices that negate the negative effects of nystagmus continue to undergo development research. These and other medical, surgical, and optical devices are potentially useful alone or in combination with other therapies.
Similar content being viewed by others
References and Recommended Reading
Kaminski HJ, Leigh RJ: Neurobiology of eye movements: from molecules to behavior. Ann NY Acad Sci 2002, 956:1–619.
Leigh RJ, Zee DS, eds: The Neurology of Eye Movements, Ed. 3. New York: Oxford University Press; 1999
Straube A, Leigh RJ, Bronstein A, et al.: EFNS task force—therapy of nystagmus and oscillopsia. Eur J Neurol 2004, 11:83–89. This is a review of nystagmus treatment with emphasis on pathophysiologic mechanisms nystagmus and applications of treatment to these mechanisms.
Eggers SDZ, Zee DS: Evaluating the dizzy patient: bedside examination and laboratory assessment of the vestibular system. Semin Neurol 2003, 23:47–57.
Epley JM: Positional vertigo related to semicircular canalithiasis. Otolaryngol Head Neck Surg 1995, 112:154–161.
Brandt T, Steddin S, Daroff RB: Therapy for benign paroxysmal positioning vertigo, revisited. Neurology 1994, 44:796–800.
Semont A, Freyss G, Vitte E: Curing the BPPV with a liberatory maneuver. Adv Otorhinolaryngol 1988, 42:290–293.
Salvinelli F, Trivelli M, Casale M, et al.: Treatment of benign positional vertigo in the elderly: a randomized trial. Laryngoscope 2004, 114:827–831.
Radtke A, Neuhauser H, von Brevern M, et al.: A modified Epley’s procedure for self-treatment of benign paroxysmal positional vertigo. Neurology 1999, 53:1358–1360.
Radtke A, von Brevern M, Tiel-Wilck K, et al.: Self-treatment of benign paroxysmal positional vertigo: Semont maneuver vs Epley procedure. Neurology 2004, 63:150–152.
Ito M, Nisimaru N, Yamamoto M: Specific patterns of neuronal connections involved in the control of the rabbit’s vestibulo-ocular reflexes by the cerebellar flocculus. J Physiol (Lond) 1977, 265:833–854.
Leigh RJ: Potassium channels, the cerebellum, and treatment for downbeat nystagmus. Neurology 2003, 61:158–159. An expert review of a current hypothesis of downbeat nystagmus and explanation of the emerging treatment of downbeat nystagmus with potassium channel blockade.
Strupp M, Schuler O, Krafczyk S, et al.: Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 2003, 61:165–170. This is a placebo-controlled, double-blind, crossover trial of 3,4-diaminopyridine for treatment of downbeat nystagmus. Analysis of quantitative eye movement recordings showed this treatment to be highly effective in suppressing nystagmus velocity and decreasing oscillopsia.
Etzion Y, Grossman Y: Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res 2001, 139:419–425.
Kalla R, Glasauer S, Schautzer F, et al.: 4-Aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain. Neurology 2004, 62:1228–1229.
Young YH, Huang TW: Role of clonazepam in the treatment of idiopathic downbeat nystagmus. Laryngoscope 2001, 111:1490–1493.
Leigh RJ, Tomsak RL. Drug treatments for eye movement disorders. J Neurol Neurosurg Psychiatry 2003;74:1–4.
Jen J, Kim GW, Baloh RW: Clinical spectrum of episodic ataxia type 2. Neurology 2004, 62:17–22. This is a review of the clinical manifestations of the calcium channelopathy episodic ataxia type 2 and genetic mutations identified in the CACNA1A gene.
Griggs RC, Moxley III RT, Lafrance RA, McQuillen J: Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 1978, 28:1259–1264.
Strupp M, Kalla R, Dichgans M, et al.: Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 2004, 62:1623–1625.
Cohen B, Helwig D, Raphan T: Baclofen and velocity storage: A model of the effects of the drug on the vestibulo-ocular reflex in the rhesus monkey. J Physiol (Lond) 1987, 393:703–725.
Solomon D, Shepard N, Mishra A: Congenital periodic alternating nystagmus: response to baclofen. Ann NY Acad Sci 2002, 956:611–616.
Averbuch-Heller L, Tusa RJ, Fuhry L, et al.: A doubleblind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997, 41:818–825.
Bandini F, Castello E, Mazzella L, et al.: Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis? J Neurol Neurosurg Psychiatry 2001, 71:107–110.
Starck M, Albrecht H, Pollman W, et al.: Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol 1997, 244:9–16.
Graf M: Kestenbaum and artificial divergence surgery for abnormal head turn secondary to nystagmus. Specific and nonspecific effects of artificial divergence. Strabismus 2002, 10:69–74.
Kose S, Egrilmez DG, Uretmen O, et al.: Retroequatorial recession of horizontal recti with loop suture in the treatment of congenital nystagmus. Strabismus 2003, 11:119–128.
Dell’Osso LF, Flynn JT: Congenital nystagmus surgery: a quantitative evaluation of the effects. Arch Ophthalmol 1979, 97:462–469.
Alio JL, Chipont E, Mulet E, De La Hoz F: Visual performance after congenital nystagmus surgery using extended hang back recession of the four horizontal rectus muscles. Eur J Ophthalmol 2003, 13:415–423.
Erbagci I, Gungor K, Bekir NA: Effectiveness of retroequatorial recession surgery in congenital nystagmus. Strabismus 2004, 12:35–40.
Dell’Osso LF. Extraocular muscle tenotomy, dissection, and suture: a hypothetical therapy for congenital nystagmus. J Pediatr Ophthalmol Strabismus 1998;35:232–233.
Dell’Osso LF: Development of new treatments for congenital nystagmus. Ann NY Acad Sci 2002, 956:361–379.
Büttner-Ennever JA, Horn AK, Graf W, Ugolini G: Modern concepts of brainstem anatomy: from extraocular motoneurons to proprioceptive pathways. Ann NY Acad Sci 2002, 956:75–84.
Dell’Osso LF, Hertle RW, Williams RW, Jacob JB: A new surgery for congenital nystagmus: effects of tenotomy on an achiasmatic canine and the role of extraocular proprioception. J AAPOS 1999, 3:166–182.
Wong AM, Tychsen L: Effects of extraocular muscle tenotomy on congenital nystagmus in macaque monkeys. J AAPOS 1999, 6:100–107.
Hertle RW, Dell’Osso LF, FitzGibbon EJ, et al.: Horizontal rectus tenotomy in patients with congenital nystagmus: results in 10 adults. Ophthalmology 2003, 110:2097–2105.
Campos EC, Schiavi C, Bellusci C: Surgical management of anomalous head posture of horizontal gaze palsy or acquired vertical nystagmus. Eye 2003, 17:587–592.
Depalo C, Hertle RW, Yang D. Eight eye muscle surgical treatment in a patient with acquired nystagmus and strabismus: a case report. Binocul Vis Strabismus Q 2003;18:151–158.
Castillo IG, Reinecke RD, Sergott RC, Wizov S: Surgical treatment of trauma-induced periodic alternating nystagmus. Ophthalmology 2004, 111:180–183.
Hertle RW: Examination and refractive management of patients with nystagmus. Surv Ophthalmol 2000, 45:215–222.
Rushton D, Cox N: A new optical treatment for oscillopsia. J Neurol Neurosurg Psychiatry 1987, 50:411–415.
Yaniglos SS, Leigh RJ: Refinement of an optical device that stabilizes vision in patients with nystagmus. Optom Vis Sci 1992, 69:447–450.
Yaniglos SS, Stahl JS, Leigh RJ: Evaluation of current optical methods for treating the visual consequences of nystagmus. Ann NY Acad Sci 2002, 956:598–600.
Biousse V, Tusa RJ, Russel B, et al.: The use of contact lenses to treat visually symptomatic congenital nystagmus. J Neurol Neurosurg Psychiatry 2004, 75:314–316.
Stahl JS, Lehmkuhle M, Wu K, et al.: Prospects for treating acquired pendular nystagmus with servo-controlled optics. Invest Ophthalmol Vis Sci 2000, 41:1084–1090.
Stahl JS, Plant GT, Leigh RJ: Medical treatment of nystagmus and its visual consequences. J R Soc Med 2002, 95:235–237.
Traccis S, Rosati G, Monaco MF, et al.: Successful treatment of acquired pendular elliptical nystagmus in multiple sclerosis with isoniazid and base-out prisms. Neurology 1990, 40:492–494.
Jain S, Proudlock F, Constantinescu CS, Gottlob I: Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis. Am J Ophthalmol 2002, 134:780–782.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rucker, J.C. Current treatment of nystagmus. Curr Treat Options Neurol 7, 69–77 (2005). https://doi.org/10.1007/s11940-005-0008-0
Issue Date:
DOI: https://doi.org/10.1007/s11940-005-0008-0